Stay updated on Gilead Sciences Press Releases
Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.

Latest updates to the Gilead Sciences Press Releases page
- Check4 days agoChange DetectedAdds a May 27, 2026 press release entry for Phase 3 ASSURE Interim Data on Livdelzi (Seladelpar) to the News Releases list, expanding the page with a new clinical update. Also removes the May 7, 2026 'Gilead Sciences Announces First Quarter Financial Results' entry from the list.SummaryDifference3%

- Check11 days agoChange DetectedNew press releases for May 21–22, 2026 appear in the News Releases list, including FDA accelerated approval for Hepcludex and a CHMP positive opinion for Trodelvy, along with other 2026 headlines; older entries from April 2026 were removed from the list.SummaryDifference4%

- Check19 days agoChange DetectedTwo new press releases were added to the Newsroom: 'Gilead Prices $3 Billion of Senior Unsecured Notes' (May 14, 2026) and 'Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026' (May 13, 2026). Older items were removed (April 14, 2026 and April 7, 2026), and the pagination page index shifted from 244 to 245.SummaryDifference4%

- Check26 days agoChange DetectedA new May 7, 2026 press release about the first quarter financial results was added to the News Releases list, and the April 1, 2026 release about extending the Arcellx tender offer was removed.SummaryDifference4%

- Check33 days agoChange DetectedNew press releases were added to the News Releases list for late April and May 2026, including investor conference announcements, a FDA priority review, and an acquisition, while several older releases from March and February 2026 were removed from the listing.SummaryDifference4%

- Check40 days agoChange Detected## Press releases list updated The newsroom “News Releases” pagination and featured items have been updated by adding newer entries (e.g., a Q1 2026 financial results release on May 7, 2026 and regulatory approvals/tender offer extension for the Arcellx acquisition) and removing older listed releases (including an investor-conference presentation and a prior acquisition-focused announcement).SummaryDifference4%

Stay in the know with updates to Gilead Sciences Press Releases
Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.